| Title : GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition - Bestion_2022_Viruses_14_132 |
| Author(s) : Bestion E , Zandi K , Belouzard S , Andreani J , Lepidi H , Novello M , Rouquairol C , Baudoin JP , Rachid M , La Scola B , Mege JL , Dubuisson J , Schinazi RF , Mezouar S , Halfon P |
| Ref : Viruses , 14 :132 , 2022 |
| Abstract : |
| PubMedSearch : Bestion_2022_Viruses_14_132 |
| PubMedID: 35062337 |
| Title : First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561\/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers - Harding_2022_Liver.Cancer_11_268 |
| Author(s) : Harding JJ , Awada A , Roth G , Decaens T , Merle P , Kotecki N , Dreyer C , Ansaldi C , Rachid M , Mezouar S , Menut A , Bestion EN , Paradis V , Halfon P , Abou-Alfa GK , Raymond E |
| Ref : Liver Cancer , 11 :268 , 2022 |
| Abstract : |
| PubMedSearch : Harding_2022_Liver.Cancer_11_268 |
| PubMedID: 35949290 |
| Title : GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions - Brun_2022_Autophagy_18_678 |
| Author(s) : Brun S , Bestion E , Raymond E , Bassissi F , Jilkova ZM , Mezouar S , Rachid M , Novello M , Tracz J , Hama A , Lalmanach G , Vanderlynden L , Legouffe R , Stauber J , Schubert T , Plach MG , Courcambeck J , Drouot C , Jacquemot G , Serdjebi C , Roth G , Baudoin JP , Ansaldi C , Decaens T , Halfon P |
| Ref : Autophagy , 18 :678 , 2022 |
| Abstract : |
| PubMedSearch : Brun_2022_Autophagy_18_678 |
| PubMedID: 34740311 |
| Gene_locus related to this paper: human-PPT1 |
| Title : GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition - Bestion_2022_Viruses_14_132 |
| Author(s) : Bestion E , Zandi K , Belouzard S , Andreani J , Lepidi H , Novello M , Rouquairol C , Baudoin JP , Rachid M , La Scola B , Mege JL , Dubuisson J , Schinazi RF , Mezouar S , Halfon P |
| Ref : Viruses , 14 :132 , 2022 |
| Abstract : |
| PubMedSearch : Bestion_2022_Viruses_14_132 |
| PubMedID: 35062337 |
| Title : First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561\/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers - Harding_2022_Liver.Cancer_11_268 |
| Author(s) : Harding JJ , Awada A , Roth G , Decaens T , Merle P , Kotecki N , Dreyer C , Ansaldi C , Rachid M , Mezouar S , Menut A , Bestion EN , Paradis V , Halfon P , Abou-Alfa GK , Raymond E |
| Ref : Liver Cancer , 11 :268 , 2022 |
| Abstract : |
| PubMedSearch : Harding_2022_Liver.Cancer_11_268 |
| PubMedID: 35949290 |
| Title : GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions - Brun_2022_Autophagy_18_678 |
| Author(s) : Brun S , Bestion E , Raymond E , Bassissi F , Jilkova ZM , Mezouar S , Rachid M , Novello M , Tracz J , Hama A , Lalmanach G , Vanderlynden L , Legouffe R , Stauber J , Schubert T , Plach MG , Courcambeck J , Drouot C , Jacquemot G , Serdjebi C , Roth G , Baudoin JP , Ansaldi C , Decaens T , Halfon P |
| Ref : Autophagy , 18 :678 , 2022 |
| Abstract : |
| PubMedSearch : Brun_2022_Autophagy_18_678 |
| PubMedID: 34740311 |
| Gene_locus related to this paper: human-PPT1 |
| Title : GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition - Bestion_2022_Viruses_14_132 |
| Author(s) : Bestion E , Zandi K , Belouzard S , Andreani J , Lepidi H , Novello M , Rouquairol C , Baudoin JP , Rachid M , La Scola B , Mege JL , Dubuisson J , Schinazi RF , Mezouar S , Halfon P |
| Ref : Viruses , 14 :132 , 2022 |
| Abstract : |
| PubMedSearch : Bestion_2022_Viruses_14_132 |
| PubMedID: 35062337 |
| Title : First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561\/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers - Harding_2022_Liver.Cancer_11_268 |
| Author(s) : Harding JJ , Awada A , Roth G , Decaens T , Merle P , Kotecki N , Dreyer C , Ansaldi C , Rachid M , Mezouar S , Menut A , Bestion EN , Paradis V , Halfon P , Abou-Alfa GK , Raymond E |
| Ref : Liver Cancer , 11 :268 , 2022 |
| Abstract : |
| PubMedSearch : Harding_2022_Liver.Cancer_11_268 |
| PubMedID: 35949290 |
| Title : GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions - Brun_2022_Autophagy_18_678 |
| Author(s) : Brun S , Bestion E , Raymond E , Bassissi F , Jilkova ZM , Mezouar S , Rachid M , Novello M , Tracz J , Hama A , Lalmanach G , Vanderlynden L , Legouffe R , Stauber J , Schubert T , Plach MG , Courcambeck J , Drouot C , Jacquemot G , Serdjebi C , Roth G , Baudoin JP , Ansaldi C , Decaens T , Halfon P |
| Ref : Autophagy , 18 :678 , 2022 |
| Abstract : |
| PubMedSearch : Brun_2022_Autophagy_18_678 |
| PubMedID: 34740311 |
| Gene_locus related to this paper: human-PPT1 |
| Title : GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer - Brun_2021_J.Cancer_12_5432 |
| Author(s) : Brun S , Pascussi JM , Gifu EP , Bestion E , Macek-Jilkova Z , Wang G , Bassissi F , Mezouar S , Courcambeck J , Merle P , Decaens T , Pannequin J , Halfon P , Caron de Fromentel C |
| Ref : J Cancer , 12 :5432 , 2021 |
| Abstract : |
| PubMedSearch : Brun_2021_J.Cancer_12_5432 |
| PubMedID: 34405006 |
| Title : GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer - Brun_2021_J.Cancer_12_5432 |
| Author(s) : Brun S , Pascussi JM , Gifu EP , Bestion E , Macek-Jilkova Z , Wang G , Bassissi F , Mezouar S , Courcambeck J , Merle P , Decaens T , Pannequin J , Halfon P , Caron de Fromentel C |
| Ref : J Cancer , 12 :5432 , 2021 |
| Abstract : |
| PubMedSearch : Brun_2021_J.Cancer_12_5432 |
| PubMedID: 34405006 |
| Title : GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer - Brun_2021_J.Cancer_12_5432 |
| Author(s) : Brun S , Pascussi JM , Gifu EP , Bestion E , Macek-Jilkova Z , Wang G , Bassissi F , Mezouar S , Courcambeck J , Merle P , Decaens T , Pannequin J , Halfon P , Caron de Fromentel C |
| Ref : J Cancer , 12 :5432 , 2021 |
| Abstract : |
| PubMedSearch : Brun_2021_J.Cancer_12_5432 |
| PubMedID: 34405006 |
| Title : GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition - Halfon_2020_bioRxiv__ |
| Author(s) : Halfon P , Bestion E , Zandi K , Andreani J , Baudoin JP , La Scola B , Mege JL , Mezouar S , Schinazi RF |
| Ref : bioRxiv , : , 2020 |
| Abstract : |
| PubMedSearch : Halfon_2020_bioRxiv__ |
| PubMedID: 33052342 |
| Title : GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition - Halfon_2020_bioRxiv__ |
| Author(s) : Halfon P , Bestion E , Zandi K , Andreani J , Baudoin JP , La Scola B , Mege JL , Mezouar S , Schinazi RF |
| Ref : bioRxiv , : , 2020 |
| Abstract : |
| PubMedSearch : Halfon_2020_bioRxiv__ |
| PubMedID: 33052342 |
| Title : GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition - Halfon_2020_bioRxiv__ |
| Author(s) : Halfon P , Bestion E , Zandi K , Andreani J , Baudoin JP , La Scola B , Mege JL , Mezouar S , Schinazi RF |
| Ref : bioRxiv , : , 2020 |
| Abstract : |
| PubMedSearch : Halfon_2020_bioRxiv__ |
| PubMedID: 33052342 |